Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women - Nappi, Rossella E.; Paoletti, Anna Maria; Volpe, Annibale; Chiovato, Luca; Howard, Brandon; Weiss, Herman; Ricciotti, Nancy (The European journal of contraception & reproductive health care, 2014)
Keywords: Adolescent; Adult; Birth control; Blood Coagulation - drug effects; Coagulation; Combined oral contraceptives; Comparative analysis; Contraceptives, Oral, Combined - adverse effects; Contraceptives, Oral, Combined - pharmacology; Contraceptives, Oral, Combined - therapeutic use; Delayed-Action Preparations - adverse effects; Delayed-Action Preparations - therapeutic use; Desogestrel; Desogestrel - administration & dosage; Desogestrel - adverse effects; Desogestrel - therapeutic use; Drug Administration Schedule; Ethinyl Estradiol - administration & dosage; Ethinyl Estradiol - adverse effects; Ethinyl Estradiol - pharmacology; Ethinyl Estradiol - therapeutic use; Factor VII - analysis; Factor VIII - analysis; Female; Fibrin Fibrinogen Degradation Products - analysis; Haemostatic; Hormones; Humans; Levonorgestrel; Levonorgestrel - administration & dosage; Levonorgestrel - adverse effects; Levonorgestrel - pharmacology; Levonorgestrel - therapeutic use; Medical treatment; Original; Partial Thromboplastin Time; Prothrombin - analysis; Womens health; Young Adult; Desogestrel; Haemostatic; Coagulation; Levonorgestrel; Combined oral contraceptives